✦ LIBER ✦

Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone

✍ Scribed by Tomita, Naoto; Takasaki, Hirotaka; Ishiyama, Yasufumi; Kishimoto, Kumiko; Ishibashi, Daisuke; Koyama, Satoshi; Ishii, Yoshimi; Takahashi, Hiroyuki; Numata, Ayumi; Watanabe, Reina; Tachibana, Takayoshi; Ohshima, Rika; Hagihara, Maki; Hashimoto, Chizuko; Takemura, Sachiya; Taguchi, Jun; Fujimaki, Katsumichi; Sakai, Rika; Motomura, Shigeki; Ishigatsubo, Yoshiaki

Book ID: 124166833
Publisher: Informa plc
Year: 2014
Tongue: English
Weight: 351 KB
Volume: 56
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2014.931953

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epratuzumab with rituximab, cyclophospha

Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma

✍ Micallef, I. N. M.; Maurer, M. J.; Wiseman, G. A.; Nikcevich, D. A.; Kurtin, P. 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 193 KB

Prognostic significance of MYC, BCL2, an

Prognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximab

✍ Nalan Akyurek; Aysegul Uner; Mustafa Benekli; Ibrahim Barista 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

Cost utility in the United States of rit

Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma

✍ John C. Hornberger; Jennie H. Best 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

A pilot study of epratuzumab and rituxim

A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma

✍ Ivana N. M. Micallef; Brad S. Kahl; Matthew J. Maurer; Ahmet Dogan; Stephen M. A 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

ABCG2 Q141K polymorphism is associated w

ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/ vincristine/prednisone chemotherapy

✍ In-Suk Kim; Hoon-Gu Kim; Dong Chul Kim; Hyeon-Seok Eom; Sun-Young Kong; Ho-Jin S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Successful Treatment of Diffuse Large B-

Successful Treatment of Diffuse Large B-Cell Non-Hodgkin Lymphoma with Modified CHOP (Cyclophosphamide/Doxorubicin/Vincristine/ Prednisone) Chemotherapy and Rituximab in a Patient with Nijmegen Syndrome

✍ Dumic, Miroslav; Radman, Ivo; Krnic, Nevena; Nola, Marin; Kusec, Rajko; Begovic, 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 885 KB